000 01339 a2200373 4500
005 20250512002837.0
264 0 _c19891004
008 198910s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-198907000-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPersson, B
245 0 0 _aLong-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cJul 1989
300 _a22-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCalcium Channel Blockers
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aIsradipine
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyridines
_xadverse effects
650 0 4 _aRandom Allocation
650 0 4 _aRenal Circulation
_xdrug effects
650 0 4 _aRenin
_xblood
700 1 _aWysocki, M
700 1 _aAndersson, O K
773 0 _tJournal of cardiovascular pharmacology
_gvol. 14
_gno. 1
_gp. 22-4
856 4 0 _uhttps://doi.org/10.1097/00005344-198907000-00005
_zAvailable from publisher's website
999 _c2481715
_d2481715